Department of Neonatal and Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC-Sophia Children's Hospital, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Department of Cardiothoracic Surgery, Erasmus MC, Rotterdam, The Netherlands.
Crit Care. 2024 Apr 30;28(1):143. doi: 10.1186/s13054-024-04905-3.
To determine whether intermittent intravenous (IV) paracetamol as primary analgesic would significantly reduce morphine consumption in children aged 0-3 years after cardiac surgery with cardiopulmonary bypass.
Multi-center, randomized, double-blinded, controlled trial in four level-3 Pediatric Intensive Care Units (PICU) in the Netherlands and Belgium. Inclusion period; March 2016-July 2020. Children aged 0-3 years, undergoing cardiac surgery with cardiopulmonary bypass were eligible. Patients were randomized to continuous morphine or intermittent IV paracetamol as primary analgesic after a loading dose of 100 mcg/kg morphine was administered at the end of surgery. Rescue morphine was given if numeric rating scale (NRS) pain scores exceeded predetermined cutoff values. Primary outcome was median weight-adjusted cumulative morphine dose in mcg/kg in the first 48 h postoperative. For the comparison of the primary outcome between groups, the nonparametric Van Elteren test with stratification by center was used. For comparison of the proportion of patients with one or more NRS pain scores of 4 and higher between the two groups, a non-inferiority analysis was performed using a non-inferiority margin of 20%.
In total, 828 were screened and finally 208 patients were included; parents of 315 patients did not give consent and 305 were excluded for various reasons. Fourteen of the enrolled 208 children were withdrawn from the study before start of study medication leaving 194 patients for final analysis. One hundred and two patients received intermittent IV paracetamol, 106 received continuous morphine. The median weight-adjusted cumulative morphine consumption in the first 48 h postoperative in the IV paracetamol group was 5 times lower (79%) than that in the morphine group (median, 145.0 (IQR, 115.0-432.5) mcg/kg vs 692.6 (IQR, 532.7-856.1) mcg/kg; P < 0.001). The rescue morphine consumption was similar between the groups (p = 0.38). Non-inferiority of IV paracetamol administration in terms of NRS pain scores was proven; difference in proportion - 3.1% (95% CI - 16.6-10.3%).
In children aged 0-3 years undergoing cardiac surgery, use of intermittent IV paracetamol reduces the median weight-adjusted cumulative morphine consumption in the first 48 h after surgery by 79% with equal pain relief showing equipoise for IV paracetamol as primary analgesic. Trial Registration Clinicaltrials.gov, Identifier: NCT05853263; EudraCT Number: 2015-001835-20.
为了确定在体外循环心脏手术后,间歇性静脉注射(IV)扑热息痛作为主要镇痛剂是否会显著减少 0-3 岁儿童的吗啡用量。
这是一项在荷兰和比利时的四个三级儿科重症监护病房(PICU)进行的多中心、随机、双盲、对照试验。纳入期为 2016 年 3 月至 2020 年 7 月。接受体外循环心脏手术的 0-3 岁儿童符合条件。在手术结束时给予 100 mcg/kg 吗啡负荷剂量后,患者被随机分配接受持续吗啡或间歇性 IV 扑热息痛作为主要镇痛剂。如果数字评分量表(NRS)疼痛评分超过预定的截止值,则给予吗啡解救。主要结局为术后 48 小时内体重校正累积吗啡剂量的中位数(mcg/kg)。为了比较两组之间主要结局的差异,采用了非参数范埃尔滕(Van Elteren)检验,并按中心进行了分层。为了比较两组中 NRS 疼痛评分≥4 的患者比例,采用非劣效性分析,非劣效性边界为 20%。
共筛选了 828 名患儿,最终纳入了 208 名患儿;315 名患儿的家长未同意,305 名患儿因各种原因被排除。在开始研究药物治疗之前,纳入的 208 名患儿中有 14 名退出了研究,最终有 194 名患儿进行了最终分析。102 名患儿接受间歇性 IV 扑热息痛治疗,106 名患儿接受持续吗啡治疗。IV 扑热息痛组术后 48 小时内体重校正累积吗啡消耗量中位数降低了 5 倍(79%),吗啡组为 145.0(IQR,115.0-432.5)mcg/kg 与 692.6(IQR,532.7-856.1)mcg/kg;P < 0.001)。两组解救吗啡用量相似(p=0.38)。IV 扑热息痛在 NRS 疼痛评分方面的非劣效性得到证实;比例差异为-3.1%(95%CI-16.6-10.3%)。
在 0-3 岁接受心脏手术的儿童中,使用间歇性 IV 扑热息痛可使术后 48 小时内的体重校正累积吗啡消耗量减少 79%,且疼痛缓解程度相同,表明 IV 扑热息痛作为主要镇痛剂具有等效性。
Clinicaltrials.gov,标识符:NCT05853263;EudraCT 编号:2015-001835-20。